Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669305 | SCV000794047 | pathogenic | Cobalamin C disease | 2017-09-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000669305 | SCV004193198 | pathogenic | Cobalamin C disease | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000669305 | SCV004292317 | pathogenic | Cobalamin C disease | 2024-03-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr105*) in the MMACHC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MMACHC are known to be pathogenic (PMID: 16311595). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with combined methylmalonic aciduria and homocystinuria (PMID: 20631720, 29731766, 31998365). ClinVar contains an entry for this variant (Variation ID: 553788). For these reasons, this variant has been classified as Pathogenic. |